Columbia University

Technology Ventures

ADDF-Harrington Scholar Awards

Monday, May 18, 2020 - 5:00pm
The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute® (HDI) have partnered to accelerate the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer’s disease and related dementias. The ADDFHarrington Scholar Award provides dedicated support from a project management team and pharmaceutical industry experts, as well as funding of up to $600,000 for 2 years.
Eligibility: MD or PhD researchers in the U.S., Canada and U.K.
Areas of Focus: Novel approaches to treat Alzheimer’s disease and related dementias. Of particular interest are targets related to proteostasis and neurovascular health.
Award Benefits:
  • Grant Funding
  • Drug discovery and pharma expertise
  • Business and commercialization advice
  • Ability to maximize potential for clinical success

Call for letters of intent opens: March 3, 2020
Letters of intent deadline: May 18, 2020
Full application deadline for those invited: July 31, 2020
Scholars announced: December 2020